We Are Innovators of Novel Therapies and Diagnostics for Unmet Medical Needs
First Line of Defense Against Dietary Free Sugar!
Prevention and Management ofDiabetes and Its Complications
Sugardown® Reduces After-Meal Level Up To 60%
Treatment of Ischemic ConditionsWhich May Lead to Necrosis
Transfusion & Blood Therapeuticsfor Veterinary Care
Automatic Retinal Imaging AnalysisFor Vascular Risk Assessment
We are a pharmaceutical company focused on the development, manufacturing and commercialization of novel compounds to address unmet medical needs in diabetes.
Read More • 1:55 pm EDT
View All News
View Investor Relations